title: Tumor-associated antigens in breast cancer.
abstract: The targets for the immune system are antigens present on cancer cells; however, many are not cancer-specific and may also be found on normal tissues. These antigens are often products of mutated cellular genes, aberrantly expressed normal genes, or genes encoding viral proteins. Vaccines constitute an active and specific immunotherapy designed to stimulate the intrinsic antitumor immune response by presenting tumor-associated antigens expressed on normal tissues that are overexpressed on tumor cells.
authors.affiliation: European Institute of Oncology, Milan, Italy.
authors.forename: Carmen
authors.initials: C
authors.lastname: Criscitiello
keywords: Breast cancer; Tumor antigen; Vaccine
references.citation: Proc Natl Acad Sci U S A. 2004 Sep 21;101(38):13885-90
references.pmid: 15365188
references.citation: Cancer Res. 1994 Oct 1;54(19):5186-93
references.pmid: 7923138
references.citation: Clin Cancer Res. 2009 Sep 15;15(18):5937-44
references.pmid: 19723649
references.citation: Cancer Immunol Immunother. 1993;36(1):9-17
references.pmid: 8422670
references.citation: Nature. 1991 Oct 3;353(6343):431-4
references.pmid: 1654525
references.citation: Cancer Res. 1996 Jul 15;56(14):3315-9
references.pmid: 8764127
references.citation: Blood Cells Mol Dis. 2008 Jan-Feb;40(1):113-6
references.pmid: 17855129
references.citation: Immunol Today. 1997 Apr;18(4):175-82
references.pmid: 9136454
references.citation: J Clin Oncol. 2005 Feb 1;23(4):720-31
references.pmid: 15613691
references.citation: J Clin Oncol. 2000 Dec 1;18(23):3964-73
references.pmid: 11099326
references.citation: Bone Marrow Transplant. 2000 Jun;25(12):1233-41
references.pmid: 10871727
references.citation: J Immunother. 1999 Jan;22(1):54-66
references.pmid: 9924700
references.citation: Hum Mol Genet. 2006 Oct 15;15 Spec No 2:R196-201
references.pmid: 16987884
references.citation: Blood. 2009 Jun 25;113(26):6541-8
references.pmid: 19389880
references.citation: Leuk Res. 2007 Mar;31(3):395-7
references.pmid: 16828156
references.citation: J Clin Invest. 2001 Feb;107(4):477-84
references.pmid: 11181647
references.citation: Clin Cancer Res. 2003 Aug 15;9(9):3222-34
references.pmid: 12960107
references.citation: Int J Cancer. 1998 Jun 10;76(6):817-23
references.pmid: 9626347
references.citation: Cancer Immunol Immunother. 1996 Nov;43(3):127-34
references.pmid: 9001565
references.citation: J Immunol. 1995 Dec 1;155(11):5089-94
references.pmid: 7594517
references.citation: Clin Cancer Res. 2000 May;6(5):1693-701
references.pmid: 10815887
references.citation: Br J Cancer. 1996 Oct;74(8):1292-6
references.pmid: 8883420
references.citation: Cancer Immunol Immunother. 2004 Dec;53(12):1068-84
references.pmid: 15696607
references.citation: Microbiol Immunol. 2007;51(5):519-30
references.pmid: 17579261
references.citation: Gene. 2003 Feb 27;305(2):217-23
references.pmid: 12609742
references.citation: J Immunother Emphasis Tumor Immunol. 1996 Jul;19(4):309-16
references.pmid: 8877724
references.citation: Leukemia. 2003 Jul;17(7):1301-12
references.pmid: 12835718
references.citation: Cancer Res. 2003 Mar 15;63(6):1280-7
references.pmid: 12649188
references.citation: Clin Cancer Res. 2009 Sep 1;15(17):5323-37
references.pmid: 19723653
references.citation: Nat Med. 2000 Sep;6(9):1011-7
references.pmid: 10973321
references.citation: FASEB J. 2002 Jul;16(9):1117-9
references.pmid: 12039855
references.citation: J Immunother Emphasis Tumor Immunol. 1993 Aug;14(2):136-43
references.pmid: 8280702
references.citation: Clin Cancer Res. 2001 May;7(5):1181-91
references.pmid: 11350882
references.citation: Nat Rev Immunol. 2005 Apr;5(4):296-306
references.pmid: 15803149
references.citation: J Hematother Stem Cell Res. 2002 Aug;11(4):589-99
references.pmid: 12201948
references.citation: J Immunol. 2007 Feb 15;178(4):1975-9
references.pmid: 17277099
references.citation: Vaccine. 1996 Jun;14(9):930-8
references.pmid: 8843637
references.citation: Clin Cancer Res. 1997 Jan;3(1):11-6
references.pmid: 9815531
references.citation: Blood. 1997 May 1;89(9):3486-7
references.pmid: 9129057
references.citation: Breast. 2009 Oct;18 Suppl 3:S51-4
references.pmid: 19914543
references.citation: Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10128-32
references.pmid: 7479739
references.citation: Br J Haematol. 2002 Feb;116(2):409-20
references.pmid: 11841446
references.citation: Curr Med Chem. 2006;13(20):2345-52
references.pmid: 16918359
references.citation: FASEB J. 2003 Jul;17(10):1364-6
references.pmid: 12738801
references.citation: J Clin Immunol. 2000 May;20(3):195-202
references.pmid: 10941827
references.citation: Clin Cancer Res. 2004 Feb 1;10(3):828-39
references.pmid: 14871958
references.citation: Cancer Res. 2002 Oct 15;62(20):5770-7
references.pmid: 12384537
references.citation: Microbiol Immunol. 2008 Dec;52(12):591-600
references.pmid: 19120973
references.citation: Blood. 1997 Nov 15;90(10):4230-2
references.pmid: 9354696
references.citation: Clin Cancer Res. 2007 Oct 1;13(19):5675-9
references.pmid: 17908956
references.citation: Oncogene. 2002 Jan 21;21(4):674-9
references.pmid: 11850795
references.citation: Curr Opin Immunol. 2005 Apr;17(2):170-4
references.pmid: 15766677
references.citation: J Clin Oncol. 2004 May 15;22(10):1916-25
references.pmid: 15143085